Altered hemostasis in pulmonary hypertension
Clinical experience with recombinant factor VIIa
Haemostatic system activation and prediction of vascular events in patients presenting with stable peripheral arterial disease of moderate severity
Tissue factor pathway inhibitor and anti-FXa kinetic profiles of a new low-molecular-mass heparin, Bemiparin, at therapeutic subcutaneous doses
Factor X Frankfurt I
Profibrinolytic properties characterize a stably transformed human endothelial cell line
Coagulation activation in patients with an inflammatory syndrome
Coexistence of antithrombin deficiency, factor V Leiden and hyperhomocysteinemia in a thrombotic family
A novel immunoassay for the quantification of human tissue factor binding to activated factor VII
An automated chromogenic peptide substrate assay for coagulation factor XII
The coagulation profile in hepatosplenic schistosomiasis
Familial lupus anticoagulant
Plasminogen activator inhibitor-1 promoter 4G/5G genotype is not a risk factor for myocardial infarction in a Japanese population
Heparin cofactor II
The 20210A allele of the prothrombin gene
Typical mitral stenosis found in a systemic lupus erythematosus patient with a positive lupus anticoagulant. Is there a pathogenic link?